Myelodysplastic Syndromes Clinical Trials
Myelodysplastic Syndromes clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for myelodysplastic Syndromes. Corterve aggregates actively recruiting Myelodysplastic Syndromes studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Myelodysplastic Syndromes studies
- A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsNCT06499285PHASE3TakedaMyelodysplastic SyndromesDuarte, California
- A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)NCT04256317PHASE2, PHASE3Taiho Oncology, Inc.Myelodysplastic SyndromesLos Angeles, California
- Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative NeoplasmsNCT06303193PHASE1, PHASE2National Cancer Institute (NCI)Myelodysplastic SyndromesBethesda, Maryland
- Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesNCT06398457EARLY_PHASE1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsHematologic MalignancyBaltimore, Maryland
- A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesNCT03802695PHASE1Orca Biosystems, Inc.Acute Myeloid LeukemiaDuarte, California
- Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaNCT05320198PHASE1, PHASE2Disc Medicine, IncMyelofibrosis; AnemiaGilbert, Arizona
- Co-Transplant of an Unmodified Haplo-Identical Graft With Cord BloodNCT06904482PHASE2Case Comprehensive Cancer CenteraGVHDCleveland, Ohio
- A Study of BGB-11417 in Participants With Myeloid MalignanciesNCT04771130PHASE1, PHASE2BeOne MedicinesAcute Myeloid LeukemiaDuarte, California
- Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDSNCT06846606PHASE1Auron Therapeutics, Inc.Relapsed Acute Myeloid Leukemia (AML)Duarte, California
- A Telehealth Advance Care Planning InterventionNCT05875805NAUniversity of RochesterMyeloid MalignancyRochester, New York
- Cord Blood Transplant in Adults With Blood CancersNCT05884333PHASE2Memorial Sloan Kettering Cancer CenterAcute Myelogenous Leukemia (AML)New York, New York
- A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.NCT06566742PHASE2M.D. Anderson Cancer CenterMyelodysplastic SyndromesMiami, Florida
Myelodysplastic Syndromes trials by state
Myelodysplastic Syndromes trials by metro
Frequently asked questions
- How do I find recruiting Myelodysplastic Syndromes clinical trials?
- Browse the actively recruiting Myelodysplastic Syndromes studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Myelodysplastic Syndromes clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Myelodysplastic Syndromes clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.